Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Hypertension|September 8, 2018
Mineralocorticoid Receptor and Cardiovascular DiseaseMathieu Buonafine, Benjamin Bonnard, Frédéric Jaisser
Annual Review of Physiology|February 10, 2022
Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal DiseasesJonatan Barrera-Chimal, Benjamin Bonnard, Frederic Jaisser
International Journal of Molecular Sciences|June 24, 2022
Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular InjuryToshifumi Nakamura, Benjamin Bonnard, Roberto Palacios-Ramirez, et al.
International Journal of Molecular Sciences|June 30, 2019
The Absence of Endothelial Sodium Channel α (αENaC) Reduces Renal Ischemia/Reperfusion InjuryAntoine Tarjus, Cecilia González-Rivas, Isabel Amador-Martínez, et al.
Hypertension (Dallas, Tex. : 1979)|November 19, 2021
Neutrophil Gelatinase-Associated Lipocalin From Macrophages Plays a Critical Role in Renal Fibrosis Via the CCL5 (Chemokine Ligand 5)-Th2 Cells-IL4 (Interleukin 4) PathwayBenjamin Bonnard, Jaime Ibarrola, Ixchel Lima-Posada, et al.
International Journal of Molecular Sciences|February 11, 2023
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection FractionIxchel Lima-Posada, Yohan Stephan, Matthieu Soulié, et al.
Experimental Eye Research|August 9, 2019
Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodentsJérémie Canonica, Chadi Mehanna, Benjamin Bonnard, et al.
Journal of Molecular and Cellular Cardiology|July 9, 2018
Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in miceBenjamin Bonnard, Marie Pieronne-Deperrois, Zoubir Djerada, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
CD47 Blockade Reprograms the Monocyte-Macrophage Axis to Promote Inflammation Resolution in AtherosclerosisMurat Kirtay, Mikael Ispirjan, Benjamin Bonnard, et al.
Clinical Science (London, England : 1979)|August 2, 2024
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathwayRoberto Palacios-Ramirez, Matthieu Soulié, Amaya Fernandez-Celis, et al.
Pageof 3